Overexpression of Cyclooxygenase-2 Is Associated with Breast Carcinoma and Its Poor Prognostic Factors
Open Access
- 1 December 2003
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 16 (12) , 1199-1204
- https://doi.org/10.1097/01.mp.0000097372.73582.cb
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast CancerJournal of Biological Chemistry, 2002
- Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.Endocrine-Related Cancer, 2001
- Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic MiceJournal of Biological Chemistry, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Regulation of Cyclooxygenase-2 pathway by HER2 receptorOncogene, 1999
- Nonsteroidal Antiinflammatory Drugs and Breast CancerEpidemiology, 1996
- v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription FactorJournal of Biological Chemistry, 1995
- Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.Journal of Clinical Investigation, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Inhibition of murine tumor growth and prostaglandin synthesis by indomethacinInternational Journal of Cancer, 1980